| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Alopecia as surrogate marker for chemotherapy response in patients with primary epithelial ovarian cancer: A metaanalysis of four prospective randomised phase III trials with 5114 patients
|
Sehouli, Jalid
|
|
2015
|
51 |
7 |
p. 825-832
8 p.
|
artikel
|
| 2 |
Comparative analysis of primary tumour and matched metastases in colorectal cancer patients: Evaluation of concordance between genomic and transcriptional profiles
|
Vignot, Stéphane
|
|
2015
|
51 |
7 |
p. 791-799
9 p.
|
artikel
|
| 3 |
Development and validation of prognostic nomograms for metastatic gastrointestinal stromal tumour treated with imatinib
|
Lee, Chee Khoon
|
|
2015
|
51 |
7 |
p. 852-860
9 p.
|
artikel
|
| 4 |
Early tumour shrinkage as a prognostic factor and surrogate end-point in colorectal cancer: A systematic review and pooled-analysis
|
Petrelli, Fausto
|
|
2015
|
51 |
7 |
p. 800-807
8 p.
|
artikel
|
| 5 |
Health-related quality of life impact in a randomised phase III study of the combination of dabrafenib and trametinib versus dabrafenib monotherapy in patients with BRAF V600 metastatic melanoma
|
Schadendorf, Dirk
|
|
2015
|
51 |
7 |
p. 833-840
8 p.
|
artikel
|
| 6 |
Immediate versus deferred initiation of androgen deprivation therapy in prostate cancer patients with PSA-only relapse. An observational follow-up study
|
Garcia-Albeniz, X.
|
|
2015
|
51 |
7 |
p. 817-824
8 p.
|
artikel
|
| 7 |
Mutation specific functions of EGFR result in a mutation-specific downstream pathway activation
|
Erdem-Eraslan, Lale
|
|
2015
|
51 |
7 |
p. 893-903
11 p.
|
artikel
|
| 8 |
443 paediatric cases of malignant melanoma registered with the German Central Malignant Melanoma Registry between 1983 and 2011
|
Brecht, Ines B.
|
|
2015
|
51 |
7 |
p. 861-868
8 p.
|
artikel
|
| 9 |
PG545 enhances anti-cancer activity of chemotherapy in ovarian models and increases surrogate biomarkers such as VEGF in preclinical and clinical plasma samples
|
Winterhoff, Boris
|
|
2015
|
51 |
7 |
p. 879-892
14 p.
|
artikel
|
| 10 |
Randomised phase III trial of second-line irinotecan plus cisplatin versus irinotecan alone in patients with advanced gastric cancer refractory to S-1 monotherapy: TRICS trial
|
Nishikawa, Kazuhiro
|
|
2015
|
51 |
7 |
p. 808-816
9 p.
|
artikel
|
| 11 |
RETRA exerts anticancer activity in Ewing’s sarcoma cells independent of their TP53 status
|
Sonnemann, Jürgen
|
|
2015
|
51 |
7 |
p. 841-851
11 p.
|
artikel
|
| 12 |
The forthcoming inexorable decline of cutaneous melanoma mortality in light-skinned populations
|
Autier, Philippe
|
|
2015
|
51 |
7 |
p. 869-878
10 p.
|
artikel
|
Tijdschrift beschrijving